We're facing 25 years of prosperity, freedom, and a better environment for the whole world. You got a problem with that? A bad meme - a contagious idea - began spreading through the United States in the 1980s: America is in decline, the world is going to hell, and our children's lives will be worse than our own. The particulars are now familiar: Good jobs are disappearing, working people are falling into poverty, the underclass is swelling, crime is out of control. The post-Cold War world is fragmenting, and conflicts are erupting all over the planet. The environment is imploding - with global warming and ozone depletion, we'll all either die of cancer or live in Waterworld. As for our kids, the collapsing educational system is producing either gun-toting gangsters or burger-flipping dopes who can't read. By the late 1990s, another meme began to gain ground. Borne of the surging stock market and an economy that won't die down, this one is more positive: America is finally getting its … [Read more...] about The Long Boom: A History of the Future, 1980
Public management reform a comparative analysis
Before she has sold one copy, Stormy Daniels has already broken a publishing record: the fastest publication of a book authored by a presidential mistress. Full Disclosure is scheduled to hit the shelves on Tuesday, the 621st day of the current administration, eclipsing Gennifer Flowers’ Passion and Betrayal by 211 days. But how will Daniels’ book stand up when compared with the other works in the “kiss-and-tell” presidential canon? Will it prove to be as historically consequential as Judith Exner’s My Story? Will it carry as important a social message as did Nan Britton’s The President’s Daughter? Will it humanize the president as much as did Kay Summersby Morgan’s Past Forgetting or Gunilla von Post’s Love, Jack? Will it have as powerful a life lesson as did Mimi Alford’s Once Upon a Secret? Or will it be marred by reckless conspiracy theorizing, like Madeleine Duncan Brown’s Texas in the Morning and Flowers’ … [Read more...] about I Read Every Memoir by a Presidential Mistress. Including Stormy’s.
CARLE PLACE, N.Y.--(BUSINESS WIRE)--May 1, 2018--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), a leading gourmet food and floral gift provider for all occasions, today reported results for its Fiscal 2018 third quarter ended April 1, 2018.Chris McCann, CEO of 1-800-FLOWERS.COM, Inc., said, “During the fiscal third quarter, we achieved top and bottom-line growth across all three of our business segments. This was driven by strong revenue growth for the 1-800-Flowers.com brand, where we further extended our market leading position with revenue growth of nearly nine percent for the quarter and more than ten percent during the key Valentine holiday. In addition, we saw a continuation of accelerated ecommerce growth in Harry & David, which grew at a double-digit pace during the quarter.”McCann noted that the Company’s BloomNet business returned to top and bottom-line growth during the third quarter, driven by increased sales of wholesale products and digital and web … [Read more...] about 1-800-FLOWERS.COM, Inc. Reports Results for Its Fiscal 2018 Third Quarter
CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Apr 20, 2018--Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy.Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below.Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase … [Read more...] about Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
PITTSBURGH--(BUSINESS WIRE)--Apr 18, 2018--Alcoa Corporation (NYSE: AA):Net income of $150 million, or $0.80 per shareExcluding special items, adjusted net income of $145 million, or $0.77 per share$653 million of adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) excluding special itemsRevenue of $3.1 billion$1.2 billion cash balance and $1.5 billion of debt, for net debt of $0.3 billion, as of March 31, 2018Company increased its 2018 projection for adjusted EBITDA excluding special items to $3.5 billion to $3.7 billion, up from $2.6 billion to $2.8 billion 1Company projects full-year 2018 global deficit for both alumina and aluminumAlcoa Corporation (NYSE: AA), a global leader in bauxite, alumina, and aluminum products today reported first quarter 2018 results that show resilient profitability amid lower alumina prices earlier in the year.In addition, Alcoa ended the quarter on March 31, 2018 with a cash balance of $1.2 billion, down $162 million … [Read more...] about Alcoa Corporation Reports First Quarter 2018 Results